These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 24389922)

  • 1. Functional disruption of HypB, a GTPase of Helicobacter pylori, by bismuth.
    Xia W; Li H; Sun H
    Chem Commun (Camb); 2014 Feb; 50(13):1611-4. PubMed ID: 24389922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bismuth-Induced Inactivation of Ferric Uptake Regulator from Helicobacter pylori.
    He X; Liao X; Li H; Xia W; Sun H
    Inorg Chem; 2017 Dec; 56(24):15041-15048. PubMed ID: 29200284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of fumarase by bismuth(III): implications for the tricarboxylic acid cycle as a potential target of bismuth drugs in Helicobacter pylori.
    Chen Z; Zhou Q; Ge R
    Biometals; 2012 Feb; 25(1):95-102. PubMed ID: 21818585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of EF-Ts and bismuth on EF-Tu in Helicobacter pylori: implications for an elegant timing for the introduction of EF-Ts in the elongation and EF-Tu as a potential drug target.
    Wang D; Luo B; Shan W; Hao M; Sun X; Ge R
    Metallomics; 2013 Jun; 5(7):888-95. PubMed ID: 23765120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The actions of bismuth in the treatment of Helicobacter pylori infections: an update.
    Ge R; Chen Z; Zhou Q
    Metallomics; 2012 Mar; 4(3):239-43. PubMed ID: 22358069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional disruption of peroxiredoxin by bismuth antiulcer drugs attenuates Helicobacter pylori survival.
    Chang YY; Cheng T; Yang X; Jin L; Sun H; Li H
    J Biol Inorg Chem; 2017 Jul; 22(5):673-683. PubMed ID: 28361362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metallo-GTPase HypB from Helicobacter pylori and its interaction with nickel chaperone protein HypA.
    Xia W; Li H; Yang X; Wong KB; Sun H
    J Biol Chem; 2012 Feb; 287(9):6753-63. PubMed ID: 22179820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antimicrobial effects and metabolomic footprinting of carboxyl-capped bismuth nanoparticles against Helicobacter pylori.
    Nazari P; Dowlatabadi-Bazaz R; Mofid MR; Pourmand MR; Daryani NE; Faramarzi MA; Sepehrizadeh Z; Shahverdi AR
    Appl Biochem Biotechnol; 2014 Jan; 172(2):570-9. PubMed ID: 24104691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and characterisation of bismuth(III) aminoarenesulfonate complexes and their powerful bactericidal activity against Helicobacter pylori.
    Busse M; Trinh I; Junk PC; Ferrero RL; Andrews PC
    Chemistry; 2013 Apr; 19(17):5264-75. PubMed ID: 23536213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of metal on the biochemical properties of Helicobacter pylori HypB, a maturation factor of [NiFe]-hydrogenase and urease.
    Sydor AM; Liu J; Zamble DB
    J Bacteriol; 2011 Mar; 193(6):1359-68. PubMed ID: 21239585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structural characterisation of bismuth(III) hydroxamates and their activity against Helicobacter pylori.
    Pathak A; Blair VL; Ferrero RL; Junk PC; Tabor RF; Andrews PC
    Dalton Trans; 2015 Oct; 44(38):16903-13. PubMed ID: 26352159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of NikR from Helicobacter pylori by a bismuth drug.
    Guo Y; Guan C; Wan H; Zhang Z; Li H; Sun H; Xia W
    J Inorg Biochem; 2019 Jul; 196():110685. PubMed ID: 30999221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metalloantibiotics: synthesis, characterization and antimicrobial evaluation of bismuth-fluoroquinolone complexes against Helicobacter pylori.
    Shaikh AR; Giridhar R; Megraud F; Yadav MR
    Acta Pharm; 2009 Sep; 59(3):259-71. PubMed ID: 19819823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, characterization, and anti-Helicobacter pylori activity of Bi3+-Hericium erinaceus polysaccharide complex.
    Zhu Y; Chen Y; Li Q; Zhao T; Zhang M; Feng W; Takase M; Wu X; Zhou Z; Yang L; Wu X
    Carbohydr Polym; 2014 Sep; 110():231-7. PubMed ID: 24906751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zn2+-linked dimerization of UreG from Helicobacter pylori, a chaperone involved in nickel trafficking and urease activation.
    Zambelli B; Turano P; Musiani F; Neyroz P; Ciurli S
    Proteins; 2009 Jan; 74(1):222-39. PubMed ID: 18767150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characteristics of anti-microbial agents and its clinical choice for H. pylori treatment].
    Aoyama N; Shirasaka D; Sakai T; Shirakawa K
    Nihon Rinsho; 1999 Jan; 57(1):43-52. PubMed ID: 10036934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Helicobacter pylori nickel metabolism accessory proteins needed for maturation of both urease and hydrogenase.
    Mehta N; Olson JW; Maier RJ
    J Bacteriol; 2003 Feb; 185(3):726-34. PubMed ID: 12533448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Elimination of Helicobacter pylori in patients with recurrent abdominal pain with simultaneous administration of ranitidine, bismuth subsalicylate and clarithromycin].
    Ramirez Mayans JA; Zamora Davila E; Cervantes Bustamante R; Mata Rivera N; Oyervides Garcia I; Cuevas S; Zarate Mondragón FE
    Acta Gastroenterol Latinoam; 1996; 26(5):281-3. PubMed ID: 9363265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological therapy of Helicobacter pylori infection.
    Hoffman JS
    Semin Gastrointest Dis; 1997 Jul; 8(3):156-63. PubMed ID: 9232728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabrication of bismuth subcarbonate nanotube arrays from bismuth citrate.
    Chen R; So MH; Yang J; Deng F; Che CM; Sun H
    Chem Commun (Camb); 2006 Jun; (21):2265-7. PubMed ID: 16718324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.